ARCHIVES

Two Phase III Ramucirumab Trials Both Deliver Improved Overall and Progression-Free Survival

This article is from The Cancer Letter archive.

Vol. 36 No. 10 | October 25, 2013

Download PDF Visit The Full Archive

Related Articles

New Tenure Program Begins, NIH May Have 20-30 Positions Open

August 5, 1994

Severe Shortages Of Many Cancer Drugs Affecting Practices

November 19, 2010

Avastin Improves PFS For Metastatic Colorectal Cancer In Phase III Study

February 23, 2007

Patient Groups Are Focus of New Alliances In a Shift of Cancer Advocacy Agenda

May 31, 1996

NCI 1980s Challenge: Matching Schientific Priorities With Resources, DeVita Says At Swearing-In

August 15, 1980

Bristol-Myers Squibb To Purchase DuPont Pharmaceuticals For $7.8 Billion.

June 29, 2001